in VABOMERE

What it isA boronic-acid beta-lactamase inhibitor paired with meropenem.
Why this oneTargets KPC carbapenemase, restoring meropenem to full potency in CRE infections.
What limits itKPC-specific; adds nothing against metallo-enzymes or resistant Pseudomonas.
NO BOXED WARNINGS
Defining liabilityLimited standalone evidence; infusion reactions and animal developmental toxicity
Open Vaborbactam in the interactive console ↗